Synopsis
Synopsis
0
CEP/COS
0
VMF
0
Canada
0
Australia
0
South Africa
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Antagonil
2. Cardene
3. Cardene I.v.
4. Cardene Sr
5. Dagan
6. Flusemide
7. Hydrochloride, Nicardipine
8. La, Nicardipine
9. Lecibral
10. Lincil
11. Loxen
12. Lucenfal
13. Nicardipine
14. Nicardipine La
15. Nicardipino Ratiopharm
16. Nicardipino Seid
17. Perdipine
18. Ridene
19. Vasonase
20. Y 93
21. Y-93
22. Y93
1. 54527-84-3
2. Nicardipine Hcl
3. Cardene
4. Perdipine
5. Loxen
6. Nicodel
7. Perdipina
8. Yc-93
9. Nicardipine (hydrochloride)
10. Dagan
11. Lecibral
12. Vasonase
13. Ridene
14. Yc-93 Hydrochloride
15. Nicardipinehydrochloride
16. Barizin
17. Cardepine
18. Dacarel
19. Lecibra
20. Lescodil
21. Nerdipina
22. Nicapress
23. Nicardal
24. Nicarpin
25. Nimicor
26. Rycarden
27. Vasodin
28. Nicant
29. Ranvil
30. Rydene
31. Rs-69216
32. Rs-69216-xx-07-0
33. Nsc-757855
34. Mls000069782
35. 2-(benzylmethylamino)ethyl Methyl 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)pyridine-3,5-dicarboxylatemonohydrochloride
36. Lincil
37. K5bc5011k3
38. Cardene Sr
39. 2-(benzylmethylamino)ethyl Methyl 1,4-dihydro-2,6-dimethyl-4-(m-nitrophenyl)-3,5-pyridinedicarboxylate Monohydrochloride
40. 3-{2-[benzyl(methyl)amino]ethyl} 5-methyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate Hydrochloride
41. Rs-69216xx07-0
42. Angioglebil
43. Bionicard
44. Nicardil
45. Smr000058487
46. Dafil
47. Cardene (tn)
48. 3,5-pyridinedicarboxylic Acid, 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-, Methyl 2-(methyl(phenylmethyl)amino)ethyl Ester, Monohydrochloride
49. 3-(2-(benzyl(methyl)amino)ethyl) 5-methyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate Hydrochloride
50. 5-o-[2-[benzyl(methyl)amino]ethyl] 3-o-methyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate;hydrochloride
51. Yc 93
52. Sr-01000075333
53. Einecs 259-198-4
54. Nicardipine Hydrochloride [usan:jan]
55. Nerdipine
56. Unii-k5bc5011k3
57. Ccris 8508
58. 69441-18-5
59. 3,5-pyridinedicarboxylic Acid, 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-, 3-methyl 5-(2-(methyl(phenylmethyl)amino)ethyl) Ester, Hydrochloride (1:1)
60. 3,5-pyridinedicarboxylic Acid, 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-, 3-methyl 5-[2-[methyl(phenylmethyl)amino]ethyl] Ester, Hydrochloride (1:1)
61. Prestwick_590
62. Einecs 274-007-4
63. Mfcd00057327
64. Opera_id_357
65. Cardene In 4.8% Dextrose In Plastic Container
66. Cardene In 5.0% Dextrose In Plastic Container
67. Cas-54527-84-3
68. Dsstox_cid_26992
69. Dsstox_rid_82040
70. Dsstox_gsid_46992
71. Schembl41845
72. 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)methyl-2-[methyl(phenylmethyl)amino]-3,5-pyridinedicarboxylic Acid Ethyl Ester Hydrochloride
73. Mls001146898
74. Mls002153279
75. Mls002153794
76. Nicardipine Hydrochloride,(s)
77. Spectrum1501135
78. Chebi:7551
79. Cardene In 0.83% Sodium Chloride In Plastic Container
80. Cardene In 0.86% Sodium Chloride In Plastic Container
81. Chembl1200326
82. Chembl3199626
83. Dtxsid9046992
84. Hms1569m07
85. Hms1921h21
86. Pharmakon1600-01501135
87. Bcp05610
88. Tox21_301832
89. Tox21_500809
90. Ccg-39033
91. Hy-12515a
92. Nsc757855
93. S4181
94. Tn-901
95. Nicardipine Hydrochloride [mi]
96. Akos015994734
97. Bcp9000988
98. Cs-3684
99. Ks-1276
100. Lp00809
101. Nc00578
102. Nicardipine Hydrochloride [jan]
103. Nsc 757855
104. Rs-69216-xx-07-o
105. Nicardipine Hydrochloride (jp17/usan)
106. Nicardipine Hydrochloride [usan]
107. Ncgc00094142-01
108. Ncgc00094142-02
109. Ncgc00094142-03
110. Ncgc00094142-04
111. Ncgc00094142-05
112. Ncgc00256289-01
113. Ncgc00261494-01
114. Nicardipine Hydrochloride [mart.]
115. Nicardipine Hydrochloride [vandf]
116. 2-(benzyl(methyl)amino)ethyl Methyl 1,4-dihydro-2,6-dimethyl-4-(m-nitrophenyl)pyridine-3,5-dicarboxylate Hydrochloride
117. 3,5-pyridinedicarboxylic Acid, 1,4-dihydro-2,6-dimethyl-4-(m-nitrophenyl)-, 2-(benzylmethylamino)ethyl Methyl Ester, Monohydrochloride
118. Ac-36579
119. Nicardipine Hydrochloride [usp-rs]
120. Nicardipine Hydrochloride [who-dd]
121. Nicardipine Hydrochloride, Powder, >=98%
122. Db-052598
123. Eu-0100809
124. Ft-0630671
125. N0635
126. Sw196762-3
127. D00617
128. D91754
129. N 7510
130. Nicardipine Hydrochloride [ep Monograph]
131. Nicardipine Hydrochloride [orange Book]
132. Nicardipine Hydrochloride [usp Monograph]
133. 527n843
134. A830225
135. Sr-01000075333-1
136. Sr-01000075333-5
137. W-105615
138. Q27281986
139. 12-(7-nitrobenzofurazan-4-ylamino)dodecanoicacid
140. Nicardipine Hydrochloride, European Pharmacopoeia (ep) Reference Standard
141. Nicardipine For System Suitability, European Pharmacopoeia (ep) Reference Standard
142. Nicardipine Hydrochloride, United States Pharmacopeia (usp) Reference Standard
143. 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylic Acid 3-(2-(n-benzyl-n-methylamino))-ethyl Ester 5-methyl Ester Hydrochloride
144. 2-(n-benzyl-n-methylamino)ethyl Methyl 2,6-dimethyl-4-(m-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate Hydrochloride
145. 3,5-pyridinedicarboxylic Acid, 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-,?methyl 2-[methyl(phenylmethyl)amino]ethyl Ester, Hydrochloride (1:1)
146. O5-[2-[benzyl(methyl)amino]ethyl] O3-methyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate Hydrochloride;nicardipine Hcl
Molecular Weight | 516.0 g/mol |
---|---|
Molecular Formula | C26H30ClN3O6 |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 8 |
Rotatable Bond Count | 10 |
Exact Mass | 515.1823134 g/mol |
Monoisotopic Mass | 515.1823134 g/mol |
Topological Polar Surface Area | 114 Ų |
Heavy Atom Count | 36 |
Formal Charge | 0 |
Complexity | 856 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 1 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
1 of 6 | |
---|---|
Drug Name | Cardene |
Drug Label | Cardene (nicardipine HCI) is a calcium ion influx inhibitor (slow channel blocker or calcium channel blocker). Cardene I.V. for intravenous administration contains 2.5 mg/mL of nicardipine hydrochloride. Nicardipine hydrochloride is a dihydropy... |
Active Ingredient | Nicardipine hydrochloride |
Dosage Form | Injectable; Capsule |
Route | Injection; Oral |
Strength | 25mg/10ml (2.5mg/ml); 30mg; 20mg |
Market Status | Prescription |
Company | Chiesi Usa |
2 of 6 | |
---|---|
Drug Name | Cardene sr |
Drug Label | CARDENE SR is a sustained release formulation of CARDENE. CARDENE SR capsules for oral administration each contain 30 mg, 45 mg or 60 mg of nicardipine hydrochloride. Nicardipine hydrochloride is a calcium ion influx inhibitor (slow channel block... |
Active Ingredient | Nicardipine hydrochloride |
Dosage Form | Capsule, extended release |
Route | Oral |
Strength | 60mg; 30mg |
Market Status | Prescription |
Company | Chiesi Usa |
3 of 6 | |
---|---|
Drug Name | Nicardipine hydrochloride |
PubMed Health | Nicardipine |
Drug Classes | Antianginal, Antihypertensive, Cardiovascular Agent |
Drug Label | Nicardipine hydrochloride capsules for oral administration each contain 20 mg or 30 mg of nicardipine hydrochloride. Nicardipine hydrochloride is a calcium ion influx inhibitor (slow channel blocker or calcium channel blocker).Nicardipine hydrochlori... |
Active Ingredient | Nicardipine hydrochloride |
Dosage Form | Capsule; Injectable |
Route | Injection; Oral |
Strength | 30mg; 25mg/10ml (2.5mg/ml); 20mg |
Market Status | Prescription |
Company | Exela Pharma Science; Wockhardt; Navinta; Bedford; Ani Pharms; Epic Pharma; Sun Pharma Global; Mylan Institutional; Luitpold; Mylan |
4 of 6 | |
---|---|
Drug Name | Cardene |
Drug Label | Cardene (nicardipine HCI) is a calcium ion influx inhibitor (slow channel blocker or calcium channel blocker). Cardene I.V. for intravenous administration contains 2.5 mg/mL of nicardipine hydrochloride. Nicardipine hydrochloride is a dihydropy... |
Active Ingredient | Nicardipine hydrochloride |
Dosage Form | Injectable; Capsule |
Route | Injection; Oral |
Strength | 25mg/10ml (2.5mg/ml); 30mg; 20mg |
Market Status | Prescription |
Company | Chiesi Usa |
5 of 6 | |
---|---|
Drug Name | Cardene sr |
Drug Label | CARDENE SR is a sustained release formulation of CARDENE. CARDENE SR capsules for oral administration each contain 30 mg, 45 mg or 60 mg of nicardipine hydrochloride. Nicardipine hydrochloride is a calcium ion influx inhibitor (slow channel block... |
Active Ingredient | Nicardipine hydrochloride |
Dosage Form | Capsule, extended release |
Route | Oral |
Strength | 60mg; 30mg |
Market Status | Prescription |
Company | Chiesi Usa |
6 of 6 | |
---|---|
Drug Name | Nicardipine hydrochloride |
PubMed Health | Nicardipine |
Drug Classes | Antianginal, Antihypertensive, Cardiovascular Agent |
Drug Label | Nicardipine hydrochloride capsules for oral administration each contain 20 mg or 30 mg of nicardipine hydrochloride. Nicardipine hydrochloride is a calcium ion influx inhibitor (slow channel blocker or calcium channel blocker).Nicardipine hydrochlori... |
Active Ingredient | Nicardipine hydrochloride |
Dosage Form | Capsule; Injectable |
Route | Injection; Oral |
Strength | 30mg; 25mg/10ml (2.5mg/ml); 20mg |
Market Status | Prescription |
Company | Exela Pharma Science; Wockhardt; Navinta; Bedford; Ani Pharms; Epic Pharma; Sun Pharma Global; Mylan Institutional; Luitpold; Mylan |
Antihypertensive Agents
Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS. (See all compounds classified as Antihypertensive Agents.)
Calcium Channel Blockers
A class of drugs that act by selective inhibition of calcium influx through cellular membranes. (See all compounds classified as Calcium Channel Blockers.)
Vasodilator Agents
Drugs used to cause dilation of the blood vessels. (See all compounds classified as Vasodilator Agents.)
ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 19552
Submission : 2006-06-26
Status : Active
Type : II
LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.
NDC Package Code : 42765-046
Start Marketing Date : 2022-04-14
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Octavius has been empowering lives since 1980 by providing quality products like DC granules, APIs and FDFs.
GDUFA
DMF Review : Reviewed
Rev. Date : 2022-09-15
Pay. Date : 2022-08-26
DMF Number : 37287
Submission : 2022-08-28
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 21211
Submission : 2007-12-31
Status : Active
Type : II
Date of Issue : 2019-07-22
Valid Till : 2022-07-21
Written Confirmation Number : WC-0075
Address of the Firm :
GDUFA
DMF Review : Reviewed
Rev. Date : 2017-09-28
Pay. Date : 2017-09-25
DMF Number : 10104
Submission : 1993-02-19
Status : Active
Type : II
GDUFA
DMF Review : Reviewed
Rev. Date : 2024-04-01
Pay. Date : 2024-02-21
DMF Number : 39326
Submission : 2024-01-31
Status : Active
Type : II
GDUFA
DMF Review : Reviewed
Rev. Date : 2023-02-08
Pay. Date : 2023-01-09
DMF Number : 37582
Submission : 2023-01-04
Status : Active
Type : II
NDC Package Code : 14501-0113
Start Marketing Date : 2022-12-30
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : Reviewed
Rev. Date : 2023-11-13
Pay. Date : 2023-09-25
DMF Number : 38876
Submission : 2023-09-28
Status : Active
Type : II
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
DRUG PRODUCT COMPOSITIONS
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
Patents & EXCLUSIVITIES
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
A Nicardipine manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Nicardipine, including repackagers and relabelers. The FDA regulates Nicardipine manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Nicardipine API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Nicardipine manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Nicardipine supplier is an individual or a company that provides Nicardipine active pharmaceutical ingredient (API) or Nicardipine finished formulations upon request. The Nicardipine suppliers may include Nicardipine API manufacturers, exporters, distributors and traders.
click here to find a list of Nicardipine suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Nicardipine DMF (Drug Master File) is a document detailing the whole manufacturing process of Nicardipine active pharmaceutical ingredient (API) in detail. Different forms of Nicardipine DMFs exist exist since differing nations have different regulations, such as Nicardipine USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Nicardipine DMF submitted to regulatory agencies in the US is known as a USDMF. Nicardipine USDMF includes data on Nicardipine's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Nicardipine USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Nicardipine suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Nicardipine Drug Master File in Japan (Nicardipine JDMF) empowers Nicardipine API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Nicardipine JDMF during the approval evaluation for pharmaceutical products. At the time of Nicardipine JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Nicardipine suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Nicardipine Drug Master File in Korea (Nicardipine KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Nicardipine. The MFDS reviews the Nicardipine KDMF as part of the drug registration process and uses the information provided in the Nicardipine KDMF to evaluate the safety and efficacy of the drug.
After submitting a Nicardipine KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Nicardipine API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Nicardipine suppliers with KDMF on PharmaCompass.
A Nicardipine written confirmation (Nicardipine WC) is an official document issued by a regulatory agency to a Nicardipine manufacturer, verifying that the manufacturing facility of a Nicardipine active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Nicardipine APIs or Nicardipine finished pharmaceutical products to another nation, regulatory agencies frequently require a Nicardipine WC (written confirmation) as part of the regulatory process.
click here to find a list of Nicardipine suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Nicardipine as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Nicardipine API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Nicardipine as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Nicardipine and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Nicardipine NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Nicardipine suppliers with NDC on PharmaCompass.
Nicardipine Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Nicardipine GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Nicardipine GMP manufacturer or Nicardipine GMP API supplier for your needs.
A Nicardipine CoA (Certificate of Analysis) is a formal document that attests to Nicardipine's compliance with Nicardipine specifications and serves as a tool for batch-level quality control.
Nicardipine CoA mostly includes findings from lab analyses of a specific batch. For each Nicardipine CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Nicardipine may be tested according to a variety of international standards, such as European Pharmacopoeia (Nicardipine EP), Nicardipine JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Nicardipine USP).
LOOKING FOR A SUPPLIER?